Looking to publish in Drug Delivery? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowDrug Delivery publishes open access peer-reviewed research on the development and application principles of drug delivery and targeting at molecular, cellular, and higher levels. It covers oral, pulmonary, nasal, parenteral, and transdermal delivery systems, formulations, nanomedicine, targeted delivery, biologics delivery, biomimetic strategies, theranostics, toxicology, computational approaches, veterinary applications, alternative methods to animal testing, and industrial and regulatory issues. The journal uses single-anonymous peer review and does not accept bibliometric analyses.
Looking to publish in Drug Delivery? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Drug Delivery accepts the following article types. Click on an article type to view submission instructions.
Research Articles
Review Articles
Systematic Reviews
Rapid Communications
Case Reports
Letters To The Editor
Recent Publications
Dual-ligand-modified cantharidin nanoparticles for the treatment of hepatocellular carcinoma via the inhibition of Ephb4
Wanting Jiang, Hao Zheng, Shengmei Wang, Rubing Xu, Xi Chen, Jing Yang, Xinhua Xia
Low-intensity pulsed ultrasound combined with microbubbles enhances amphotericin B delivery across the blood–brain barrier for improved therapy of cryptococcal meningitis
Junyu Liu, Zhengtu Li, Dongcheng Li, Jia Liu, Yutian Su, Yifei Leng, Yongming Li, Li Xu, Lan Sun, Xiaohong Su, Xiaotong Li, Changyong Tang, Ying Jiang, Xintao Shuai, Fuhua Peng
Dual-mechanism vitamin C delivery by polyethylene glycol-23 glyceryl distearate-based niosomes via SVCT2 induction and enhanced transdermal penetration
Tatsuro Miyoshi, Brian C. Keller, Sui Nakagawa, Takashi Ashino, Asuka Kaizaki-Mitsumoto, Satoshi Numazawa
Human factors validation study of a disposable autoinjector (Bmab 1200 autoinjector) for subcutaneous delivery of Ustekinumab
Sam Moses K, Rohini Kamaraj, Suryaprakash Konda Ramachary Subramanian
Lysosome-directed targeted protein degradation technologies for overcoming cancer drug resistance: mechanisms, design principles, and therapeutic opportunities
Huixin Mao, Ying Zhang, Mingqi Liu, Yao Yao, Yujie Peng, Xuwei Zhou, Hao Huang, Weidong Fei, Caihong Zheng, Yiqing Ye
Frequently asked questions
How long does it take to publish?
The journal reports average median day metrics for submission to first decision, submission to first post-review decision, and acceptance to online publication.
Reformat to Drug Delivery using Livewrite PremiumIs a cover letter required?
A cover letter is mandatory and should briefly explain the significance of the work and its key findings, and state whether the manuscript is a new submission or a resubmission. For resubmissions, include the original manuscript ID and the changes made.
Reformat to Drug Delivery using Livewrite PremiumWhat are the publication costs?
Open access publication may be covered through an institutional open access agreement; no journal-specific APC is stated.
Reformat to Drug Delivery using Livewrite Premium